跳转至内容
Merck
CN

PHR1252

普鲁卡因胺 盐酸盐

Pharmaceutical Secondary Standard; Certified Reference Material

别名:

4-氨基-N-(2-二乙氨基乙基)苯甲酰胺 盐酸盐, 4-氨基苯甲酸-2-二乙氨基乙酰胺

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
H2NC6H4CONHCH2CH2N(C2H5)2·HCl
化学文摘社编号:
分子量:
271.79
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
EC Number:
210-381-7
Beilstein/REAXYS Number:
3729517
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

普鲁卡因胺 盐酸盐, Pharmaceutical Secondary Standard; Certified Reference Material

InChI

1S/C13H21N3O.ClH/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11;/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17);1H

InChI key

ABTXGJFUQRCPNH-UHFFFAOYSA-N

SMILES string

Cl.CCN(CC)CCNC(=O)c1ccc(N)cc1

grade

certified reference material
pharmaceutical secondary standard

agency

traceable to Ph. Eur. P3050000
traceable to USP 1563502

API family

procainamide

CofA

current certificate can be downloaded

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

mp

167-169 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-30°C

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

盐酸普鲁卡因酰胺可用作药物参考标准品,用于通过分光光度法和电泳技术对药物制剂中的分析物进行测定。
这些二级标准品是合格的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。

General description

盐酸普鲁卡因酰胺属于I类抗心律不齐药物,用于治疗心脏病患者的心律不齐。它还对顺铂诱导的肾脏毒性有化学保护行为。
用于质量控制的药物二级标准品,为制药实验室和制造商制备内部工作标准品提供了一种方便、高性价比的替代方案。

Other Notes

在我们的NMR在线平台ChemisTwin®上可以找到本品对应的数字化标准物质。您可使用ChemisTwin®上的数字等效品鉴定您的样品并进行定量分析(使用数字化外标)。可查看该物质的NMR谱图,只需点击几次鼠标,就能进行在线样品比对。欢迎点击了解更多,开启免费试用之旅。
想要查看本品的分析证书示例,请在下框中输入LRAC4012。这只是一个示例证书,可能与您收到的批次不符。
本有证标准物质 (CRM) 按照 ISO 17034 ISO/IEC 17025 生产和认证。有关本 CRM 使用的所有信息,请参见检验报告。

Analysis Note

These secondary standards offer multi-traceability to the US and EP primary standards, where they are available.

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats
Zicca A, et al.
European Journal of Pharmacology, 442(3), 265-272 (2002)
Spectrophotometric determination of procainamide hydrochloride using sodium periodate
Al-Tamrah S and Al-Abbad,S
Arabian Journal of Chemistry, 8(5), 609-613 (2015)
Spectrophotometric determination of nicoumalone, acebutolol hydrochloride and procainamide hydrochloride
Sastry CSP, et al.
Talanta, 38(9), 1057-1060 (1991)
Fei Li et al.
Biochemical pharmacology, 83(10), 1435-1444 (2012-03-06)
Procainamide, a type I antiarrhythmic agent, is used to treat a variety of atrial and ventricular dysrhythmias. It was reported that long-term therapy with procainamide may cause lupus erythematosus in 25-30% of patients. Interestingly, procainamide does not induce lupus erythematosus
Ludovic Halby et al.
Chembiochem : a European journal of chemical biology, 13(1), 157-165 (2011-12-16)
DNA methyltransferases (DNMTs) are responsible for DNA methylation, an epigenetic modification involved in gene regulation. Families of conjugates of procainamide, an inhibitor of DNMT1, were conceived and produced by rapid synthetic pathways. Six compounds resulted in potent inhibitors of the

商品

This application note describes the released N-Glycan analysis of a monoclonal antibody, cetuximab, labeled with procainamide, using a BIOshell™ Glycan HPLC column.

Workflows for monoclonal antibody adalimumab characterization ensure drug safety and efficacy through critical quality attribute analysis.

实验方案

A step-by-step protocol for released N-linked glycan analysis of the monoclonal antibody adalimumab, based on UHPLC-FLR-MS and procainamide labeling.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持